CTRI/2022/07/044210CompletedPhase 4
EFFICACY OF KAISHORA GUGGULU AFTER VIRECHANA AS AN ADD- ON TO THE STANDARD OF CARE IN MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY : A PRE AND POST TEST CLINICAL STUDY ?
Dr VEENA VASUDEVA0 sites20 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Diagnosed cases of DSPN ( who fulfil the diagnostic criteria )
- •? Participants with HbA1c value between 7 and 8
- •? Patients up to the stage of N2a i.e., stage of mild diabetic polyneuropathy is needed to
- •be considered
- •? Participants from whom the written consent is obtained
Exclusion Criteria
- •Those with CAD, retinopathy , nephropathy diseases Those with alcoholic, smoking
- •? Participants who are having other systemic diseases.
- •? Patients having foot ulcer, cellulitis.
- •? Patient who suffer with N2b stage i.e Severe diabetic polyneuropathy
- •? Participants with HbA1C value more than 8 mg/dl
- •? Serum Creatinine value more than 1.1mg/dl
Investigators
Similar Trials
Completed
Phase 2
Evaluate the efficacy of Kaishora Guggulu with and withoutVirechana Karma in the management of Vatarakta (Gout)CTRI/2021/03/032128All India Institute of Ayurveda30
Not yet recruiting
Phase 2
A clinical trial to study the effects of Kokilakshadi ghanavati and Kaishora guggulu in patients with joint pain due to the involvement of rakta.CTRI/2023/04/051697Adhip Chand S
Not yet recruiting
Phase 2
EFFECT OF ERANDADI GHANAVATI OVER KAISHORA GUGGULU AFTER VIRECHAN IN THE PATIENTS OF VATARAKTA (CHRONIC GOUT)CTRI/2024/08/072119All India Institute of Ayurveda
Completed
Phase 2
Study on Tonsillitis in childreCTRI/2022/03/040941All India Institute of Ayurveda60
Completed
Phase 3
Efficacy of virechana and guduchayadi kwatha in obesityCTRI/2020/03/024059IPGT and RA28